It now appears that the high fasting levels of glucagon in patients with T2DM are more related the occurrence of NAFL and steatosis of the liver, which causes resistance to the actions of glucagon with resulting hyperaminoacidemia. The gene discussed is GCG; the disease is non-alcoholic fatty liver.